The Potential of SERMs for Reducing the Risk of Coronary Heart Disease

Author： Barrett-Connor E. Cox D.A. Anderson P.W.

Publisher： Elsevier

ISSN： 1043-2760

Source： Trends in Endocrinology and Metabolism, Vol.10, Iss.8, 1999-10, pp. : 320-325

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Urinary isoflavonoids and risk of coronary heart disease

By Zhang Xianglan

International Journal of Epidemiology, Vol. 41, Iss. 5, 2012-10 ,pp. : 1367-1375

Oxford University Press

Access to resources Recommend Favorite

Estrogen plus progestin and the risk of coronary heart disease

By Manson J.E. Hsia J. Johnson K.C. for the Women's Health Initiative Investigators

ACC Current Journal Review, Vol. 12, Iss. 6, 2003-11 ,pp. : 24-24

Elsevier

Access to resources Recommend Favorite

Hematological Risk Factors for Coronary Heart Disease

Medical Principles and Practice, Vol. 11, Iss. 2, 2002-11 ,pp. : 56-62

Karger

Access to resources Recommend Favorite

Assessment of coronary heart disease risk in populations with different levels of risk

By Pyörälä K.

European Heart Journal, Vol. 21, Iss. 5, 2000-03 ,pp. : 348-350

Oxford University Press

Access to resources Recommend Favorite

Plasma levels and potential roles of catestatin in patients with coronary heart disease

By Liu Lin Ding Wenhui Zhao Feng Shi Libin Pang Yongzheng Tang Chaoshu

Scandinavian Cardiovascular Journal, Vol. 47, Iss. 4, 2013-08 ,pp. : 217-224

Informa Healthcare

Access to resources Recommend Favorite